The Patent Finder

Terms ending in 2039

Element Biosciences, Inc.

Every in-force patent on Element Biosciences, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,704,094Multipart Reagents Having Increased Avidity for Polymerase Binding
In force
 · High confidence
Element Biosciences, Inc.In forceHigh confidence
US 10,876,148De Novo Surface Preparation and Uses Thereof
In force
 · High confidence
Element Biosciences, Inc.In forceHigh confidence
US 10,982,280Multipart Reagents Having Increased Avidity for Polymerase Binding
In force
 · High confidence
Element Biosciences, Inc.In forceHigh confidence
US 12,313,627Multivalent Binding Composition for Nucleic Acid Analysis
In force
 · High confidence
Element Biosciences, Inc.In forceHigh confidence
US 10,768,173Multivalent Binding Composition for Nucleic Acid Analysis
In force
 · High confidence
Element Biosciences, Inc.In forceHigh confidence
US 12,134,766Methods for Generating Circular Nucleic Acid Molecules
In force
 · High confidence
Element Biosciences, Inc.In forceHigh confidence
US 11,426,732Flow Cell Device and Use Thereof
In force
 · Medium confidence
Element Biosciences, Inc.In forceMedium confidence
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited